Am. J. Respir. Crit. Care Med., Volume 163, Number 4, March 2001, 859-864

Effects of Exercise on Amino Acid Metabolism in Patients with Chronic Obstructive Pulmonary Disease

MARIËLLE P. K. J. ENGELEN, EMIEL F. M. WOUTERS, NICOLAAS E. P. DEUTZ, JOAN D. DOES, and ANNEMIE M. W. J. SCHOLS

Departments of Pulmonology and Surgery, Maastricht University, Maastricht, The Netherlands; and Asthma Center Hornerheide, Horn, The Netherlands

Depletion of fat-free mass (FFM) significantly contributes to decreased skeletal muscle weakness and impaired exercise capacity in patients with chronic obstructive pulmonary disease (COPD). FFM wasting suggests disturbances in intermediary metabolism, confirmed by data showing profound alterations in the skeletal muscle amino acid (AA) status in COPD at rest. To unravel whether there is a role for AAs in the mechanisms for skeletal muscle dysfunction in COPD, basic knowledge of AA metabolism in the muscle during exercise is important. We examined the effects of 20 min of exercise on AA metabolism in 14 patients with COPD and eight control subjects. Arterialized venous blood and a quadriceps femoris muscle biopsy were obtained before and immediately after exercise. FFM was not significantly different between the groups. In COPD, a significant reduction of most muscle AAs was present postexercise, whereas several plasma AAs were increased (p < 0.05). Consequently, sum AAs was reduced in muscle (20%; p < 0.01) and increased in plasma (16%, p < 0.05), suggesting an enhanced AA release from muscle in COPD during exercise. In the COPD group, the increase in plasma alanine and glutamine was even higher postexercise (61%, p < 0.01 and 21%, p < 0.01, respectively), suggesting enhanced nitrogen efflux. This study shows that exercise alters amino acid (intermediary) metabolism in patients with COPD and independent of the presence of FFM wasting.

This article has been cited by other articles:

				E. P. A. Rutten, M. P.K.J. Engelen, C. L. N. Castro, E. F. M. Wouters, A. M.W.J. Schols, and N. E. P. Deutz Decreased Whole-Body and Splanchnic Glutamate Metabolism in Healthy Elderly Men and Patients with Chronic Obstructive Pulmonary Disease in the Postabsorptive State and in Response to Feeding J. Nutr., September 1, 2005; 135(9): 2166 - 2170. [Abstract] [Full Text] [PDF]

				M. P. Engelen, E. P. Rutten, C. L. De Castro, E. F. Wouters, A. M. Schols, and N. E. Deutz Altered interorgan response to feeding in patients with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, August 1, 2005; 82(2): 366 - 372. [Abstract] [Full Text] [PDF]

				Y. L. Vissers, C. H. Dejong, Y. C Luiking, K. C. Fearon, M. F von Meyenfeldt, and N. E. Deutz Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1142 - 1146. [Abstract] [Full Text] [PDF]

				M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF]

				R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF]

				A.M.W.J. Schols Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Eur. Respir. J., November 2, 2003; 22(46_suppl): 81s - 86s. [Abstract] [Full Text] [PDF]

				E F M Wouters Eat well to get well Thorax, September 1, 2003; 58(9): 739 - 740. [Full Text] [PDF]

				M. P. Engelen, N. E. Deutz, R. Mostert, E. F. Wouters, and A. M. Schols Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema Am. J. Clinical Nutrition, April 1, 2003; 77(4): 868 - 874. [Abstract] [Full Text] [PDF]

				A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				E F M Wouters Chronic obstructive pulmonary disease * 5: Systemic effects of COPD Thorax, December 1, 2002; 57(12): 1067 - 1070. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]